CClinicalTrials.gg
CompletedNCT06604819Updated Sep 20, 2024

The Impact of Ozone Gel on the Bone Height and Density

An interventional study of Ozone gel placed after closed sinus lifting then implant placed simultaneously. and closed sinus lifting using osteotomes with simultaneous implant placement in Sinus Pneumatization, sponsored by Suez Canal University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-20.

Sponsored by Suez Canal University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 8 months after the study started (first participant enrolled Dec 2021, registered Sep 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Purpose: The present study was conducted to evaluate the effect of using ozone gel with maxillary sinus elevation using tenting technique on the clinical and radiographic outcome of implants placed simultaneously..

Materials and Methods: A total of 30 sinuses with an average residual alveolar bone height ranging from 4-7 mm participated in this randomized controlled clinical trial. After closed sinus lift operation, patients were randomly and equally allocated into control group and ozone gel recipient group. Cone beam computed tomography was performed immediately and at 4 months postoperatively. Bone stability was measured immediately and at 3 \& 4 months postoperatively. Bone height and stability were evaluated radiographically, and bone stability was measured using the Osstell device.

Read the detailed description

Concern over biological augmentations used in bone healing has grown in recent years. One of the essential demands in sinus lifting procedure is to speed up the bone formation and enhance the quality of the formed bone in the space created after sinus elevation. Since more than 100 years medical grade ozone has been used as one of the non-medication methods of treatment. E. A. Fisch in the 1930's was the first dentist to use ozone therapy in his practice to aid in disinfection and wound healing. Current ozone uses a mixture of ozone gel and pure oxygen, with today's medical ozone generators which regulate the flow of medical grade O2 through high voltage tubes which is capable of producing pure ozone-oxygen mixtures in precise dosages.

Nevertheless, there is not enough evidence to support the use of ozone in oral and maxillofacial surgery. Ozone therapy has a therapeutic effect that promotes blood and growth factor supply, aids in wound healing, and may improve bone regeneration . However up till now, no studies were conducted to assess the impact of using ozone gel on bone formation in case maxillary sinus elevation.

02

Conditions studied

  • Sinus Pneumatization

Keywords

  • closed sinus lifting
03

In context

Lead sponsor

Suez Canal University is the lead sponsor of 157 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient age should be > 18 years of age.
  • Patients included were ASA I and ASA II.
  • Both males and females were included in the study.
  • Patients with need of tooth replacements in the maxillary premolar and molar area where the residual alveolar bone height ranges from 4-7 mm and bone density D3 or D4.
  • Compliance with all requirements in the study and signing the informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients with immunological diseases or diseases affecting bone healing.
  • Patients suffering from uncontrolled systemic diseases.
  • Patients with active acute infection related to the planned implant site, maxillary sinusitis or pathosis.
  • Patients with parafunctional occlusal habits.
  • Patients with bad oral hygiene.
  • Patients who were alcohol and drug abusers.
  • Heavy Smoker Patients.
  • Patients who went previous sinus lifting surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
19 participants (actual)

Study arms

  • Active comparator
    closed sinus lifting using osteotomes with simultaneous implant placement

    Full thickness mucoperiosteal flap was elevated.• The pilot drill of the implant system was used to create an osteotomy 1 mm short of the subantral floor. • The insertion of the osteotome were repeated several times until the required membrane lift was achieved then the osteotome corresponding in size to the last drill was used.After that, placement of the implant was done .Healing abutment was placed to allow for multiple times measurements of implant stability and primary closure was done and the flap was sutured in an interrupted manner using 4/0 prolene suture .

    Procedure: closed sinus lifting using osteotomes with simultaneous implant placement

  • Experimental
    closed sinus lifting using osteotomes with simultaneous implant placement with ozone gel placement

    Full thickness mucoperiosteal flap was elevated.• The pilot drill of the implant system was used to create an osteotomy 1 mm short of the subantral floor. • The insertion of the osteotome were repeated several times until the required membrane lift was achieved then the osteotome corresponding in size to the last drill was used.Ozone gel was delivered into the osteotomy . To obtain the ozone gel, pure olive oil was blasted with 25 μ/ml O3 gas for two days, or until the oil changed from a greenish-colored liquid to a whitish gel. The longevity Ext 120 ozone generator executed out this process. After that, placement of the implant was done .Healing abutment was placed to allow for multiple times measurements of implant stability and primary closure was done and the flap was sutured in an interrupted manner using 4/0 prolene suture .

    Drug: Ozone gel placed after closed sinus lifting then implant placed simultaneously.

Interventions

  • DrugOzone gel placed after closed sinus lifting then implant placed simultaneously.

    The patient received closed sinus lifting using osteotomes then ozone gel is prepared. Pure olive oil was blasted with 25 μ/ml O3 gas for two days, or until the oil changed from a greenish-colored liquid to a whitish gel. The longevity Ext 120 ozone generator executed out this process then implants were placed.

  • Procedureclosed sinus lifting using osteotomes with simultaneous implant placement

    The patient received closed sinus lifting using osteotomes with implant placed simultaneously.

06

What researchers measure

Primary outcomes

  1. Implant stability

    - Resonance frequency analysis was performed to assess implant stability. The implant stability was measured using the Osstell ISQ scale "immediate postoperative then after 3 and 4 months . The readings were taken along the three surfaces of the implant (perpendicular to the implant axis, mesial surface and distal surface). Finally, the averages of these readings were taken as a representative value for each implant .

    Time frame: Immediate postoperative,3 months and 4 months postoperative

Secondary outcomes

  1. Bone Density

    The bone density was evaluated using CBCT. To minimize the error from radiographic image alignment, the On Demand 3D fusion module software was used to generate a superimposed image at the sagittal and coronal planes of each implant to compare each parameter .

    Time frame: Immediate postoperative and 4 months postoperative

  2. Bone height gain

    Cone beam computed tomography (CBCT was taken to evaluate the accuracy of implant placement and to represent the baseline measurement for evaluation. The bone height gain was evaluated along the surface of each implant.

    Time frame: Immediate postoperative and 4 months postoperative

07

Study locations

1 site
  • Faculty of Dentistry, Suez Canal University
    Ismailia, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — It will be available upon request

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06604819
Lead sponsor
Suez Canal University
Responsible party
Dina yousry (Principle investigator "Doctorate candidate", Suez Canal University) — Principal investigator
First posted
Sep 20, 2024
Start date
Dec 21, 2021
Primary completion
Dec 15, 2022
Completion
Dec 20, 2023
Last update
Sep 20, 2024

Study contacts

Dina El-Zaefzaf, Masters
principal investigator · Faculty of Dentistry,Suez Canal University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion